Molecular testing for BRAFV600E and RAS mutations from cytoscrapes of thyroid fine needle aspirates: A single-center pilot study | Zendy

Radhika Srinivasan | Zendy; Ojas Gupta | Zendy; Upasana Gautam | Zendy; Muralidaran Chandrasekhar | Zendy; Arvind Rajwanshi | Zendy; BishanDass Radotra | Zendy; Roshan Verma | Zendy

Open Access

Molecular testing for BRAFV600E and RAS mutations from cytoscrapes of thyroid fine needle aspirates: A single-center pilot study

Author(s) -

Radhika Srinivasan,

Ojas Gupta,

Upasana Gautam,

Muralidaran Chandrasekhar,

Arvind Rajwanshi,

BishanDass Radotra,

Roshan Verma

Publication year - 2020

Publication title -

journal of cytology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.267

H-Index - 19

eISSN - 0974-5165

pISSN - 0970-9371

DOI - 10.4103/joc.joc_45_20

Subject(s) - hras , neuroblastoma ras viral oncogene homolog , kras , medicine , v600e , thyroid carcinoma , thyroid cancer , thyroid , fine needle aspiration , pathology , cancer , biopsy , mutation , biology , colorectal cancer , gene , biochemistry

Molecular testing of thyroid FNA has been advocated in the indeterminate categories of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) 2018. The utility of cytoscrapes of thyroid FNA samples for BRAF V600E and RAS mutations was evaluated in this pilot study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research